A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins
Open accessAbstract
One-fourth of all deaths in industrialized countries result from coronary heart disease. A century of research has revealed the essential causative agent: cholesterol-carrying low-density lipoprotein (LDL). LDL is controlled by specific receptors (LDLRs) in liver that remove it from blood. Mutations that eliminate LDLRs raise LDL and cause heart attacks in childhood, whereas mutations that raise LDLRs reduce LDL and diminish heart attacks. If we are to eliminate coronary disease, lowering LDL should be the primary goal. Effective means to achieve this goal are currently available. The key questions are: who to treat, when to treat, and how long to treat.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
LDLR plays a crucial role in the uptake of LDL-C from the circulation by hepatocytes.
“LDLR plays a crucial role in the uptake of LDL-C from the circulation by hepatocytes 1,2,7 .”
From Dietary cholesterol activates a Ral-dependent pathway driving LDLR turnover (2026) · cites this paper as [1]
The regulation of LDLR trafficking and turnover is essential for maintaining cholesterol homeostasis and remains a major focus of therapeutic strategies for CVD.
“The regulation of LDLR trafficking and turnover is essential for maintaining cholesterol homeostasis and remains a major focus of therapeutic strategies for CVD 1,2,7 .”
From Dietary cholesterol activates a Ral-dependent pathway driving LDLR turnover (2026) · cites this paper as [1]
Unlike common diseases, the clarity of causation for Mendelian disorders usually simplifies generating models to connect genotype to organismal phenotype, and these models have led to critical insights into human health and disease biology.
“Unlike common diseases, the clarity of causation for Mendelian disorders usually simplifies the task of generating models (including human cells and organoids or rodents) to connect genotype to organismal phenotype; these have led to many critical insights into the biology of health and disease in humans98,99.”
From A brief history of human disease genetics (2020) · cites this paper as [98]
Lifelong lower levels of plasma LDL cholesterol are much more effective than late LDL reductions induced by statins in preventing coronary heart disease.
“These data suggest that lifelong lower levels of plasma LDL cholesterol are much more effective than late LDL reductions induced by statins in preventing coronary heart disease (31).”
From Health Benefits of the Mediterranean Diet: Metabolic and Molecular Mechanisms (2018) · cites this paper as [31]
Hypercholesterolemia is one of the key risk factors in promoting atherosclerosis, which is the underlying cause of approximately 90% of cases of myocardial infarction, 60% of strokes, most cases of chronic heart failure, peripheral arterial disease, and vascular dementia.
“Hypercholesterolemia is one of the key risk factors in promoting atherosclerosis, which is the underlying cause of approximately 90% of cases of myocardial infarction, 60% of strokes, most cases of chronic heart failure, peripheral arterial disease, and vascular dementia (31).”
From Health Benefits of the Mediterranean Diet: Metabolic and Molecular Mechanisms (2018) · cites this paper as [31]
The J-shaped association between alcohol consumption and cardiovascular disease is artefactual; the apparent protective effect of moderate alcohol consumption is not causal.
“An example is the J-shaped association between alcohol consumption and cardiovascular disease; there is now consensus that this apparent protective effect of moderate levels of consumption is artefactual, as discussed above.130”
From Mendelian randomization (2022) · cites this paper as [130]
A large-effect genetic variant influencing alcohol consumption that has been of considerable value in MR studies of the effects of alcohol is only prevalent in East Asian populations.
“For example, a large-effect genetic variant influencing alcohol consumption that has been of considerable value in MR studies of the effects of alcohol75,130 is only prevalent in East Asian populations.”
From Mendelian randomization (2022) · cites this paper as [130]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467 · see citing works
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439 · see citing works
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703 · see citing works
Self-citation(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261 · see citing works
High density lipoprotein as a protective factor against coronary heart disease
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90874-9 · Cited by 5,059 · see citing works
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,285 · see citing works
Self-citationSREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092 · see citing works
Self-citationProgress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010 · see citing works
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834 · see citing works
Self-citationSCANDINAVIANSIMVASTATINSURVIVAL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90566-5 · Cited by 3,638 · see citing works
Sequence Variations in <i>PCSK9,</i> Low LDL, and Protection against Coronary Heart Disease
Cohen, J. C., Boerwinkle, E., Mosley, T. H., & Hobbs, H. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054013 · Cited by 3,181 · see citing works
Pedersen, T. R. (2004) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2004.08.027 · Cited by 3,104 · see citing works
Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,049 · see citing works
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
Abifadel, M., Varret, M., Rabès, J.-P., Allard, D., Ouguerram, K., Devillers, M., Cruaud, C., Benjannet, S., Wickham, L., Erlich, D., et al. (2003) · Nature Genetics · doi:10.1038/ng1161 · Cited by 2,985 · see citing works
Collaborators, C. T. T. (. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60367-5 · Cited by 2,833 · see citing works
The Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis
Goldstein, L. J., & Brown, S. M. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.004341 · Cited by 2,455 · see citing works
LIPOPROTEIN METABOLISM IN THE MACROPHAGE: Implications for Cholesterol Deposition in Atherosclerosis
Brown, M. S., & Goldstein, J. L. (1983) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.52.070183.001255 · Cited by 2,300 · see citing works
Self-citationBonetti, P. O., Lerman, L. O., & Lerman, A. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000051384.43104.fc · Cited by 2,199 · see citing works
Coated pits, coated vesicles, and receptor-mediated endocytosis
Goldstein, J. L., Anderson, R. G. W., & Brown, M. S. (1979) · Nature · doi:10.1038/279679a0 · Cited by 2,073 · see citing works
Self-citationFat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701052760107 · Cited by 1,911 · see citing works
Protein Sensors for Membrane Sterols
Goldstein, J. L., DeBose‐Boyd, R. A., & Brown, M. S. (2006) · Cell · doi:10.1016/j.cell.2005.12.022 · Cited by 1,685 · see citing works
Self-citationAlberts, A. W., Chen, J., Kuron, G. W., Hunt, V. M., Huff, J. W., Hoffman, C., Rothrock, J. W., López, M., Joshua, H., Harris, E., et al. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.3957 · Cited by 1,630 · see citing works
Horton, J. D., Shah, N. A., Warrington, J. A., Anderson, N. N., Park, S. W., Brown, M. S., & Goldstein, J. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1534923100 · Cited by 1,427 · see citing works
Self-citationSeven Countries: A Multivariate Analysis of Death and Coronary Heart Disease.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-5-786_2 · Cited by 1,425 · see citing works
The human LDL receptor: A cysteine-rich protein with multiple Alu sequences in its mRNA
Yamamoto, T., Davis, C. G., Brown, M. S., Schneider, W. J., Casey, M. L., Goldstein, J. L., & Russell, D. W. (1984) · Cell · doi:10.1016/0092-8674(84)90188-0 · Cited by 1,382 · see citing works
Self-citationGoldstein, J. L., & Brown, M. S. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179564 · Cited by 1,344 · see citing works
Self-citationRegulated Intramembrane Proteolysis
Brown, M. S., Ye, J., Rawson, R. B., & Goldstein, J. L. (2000) · Cell · doi:10.1016/s0092-8674(00)80675-3 · Cited by 1,329 · see citing works
Self-citationGeneral Conclusions: Teleonomic Mechanisms in Cellular Metabolism, Growth, and DifferentiationPreprint
Monod, J., & Jacob, F. (1961) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1961.026.01.048 · Cited by 1,072 · see citing works
SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis
Wang, X., Sato, R., Brown, M. S., Hua, X., & Goldstein, J. L. (1994) · Cell · doi:10.1016/0092-8674(94)90234-8 · Cited by 1,003 · see citing works
Self-citationCrucial Step in Cholesterol Homeostasis
Yang, T., Espenshade, P. J., Wright, M. E., Yabe, D., Gong, Y., Aebersold, R., Goldstein, J. L., & Brown, M. S. (2002) · Cell · doi:10.1016/s0092-8674(02)00872-3 · Cited by 987 · see citing works
Self-citationYokoyama, C., Wang, X., Briggs, M. R., Admon, A., Wu, J., Hua, X., Goldstein, J. L., & Brown, M. S. (1993) · Cell · doi:10.1016/s0092-8674(05)80095-9 · Cited by 968 · see citing works
Self-citationChen, W. J., Goldstein, J. L., & Brown, M. S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39742-x · Cited by 936 · see citing works
Self-citationOn the Regulation of Gene ActivityPreprint
Jacob, F., & Monod, J. (1961) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1961.026.01.024 · Cited by 891 · see citing works
The LDL Receptor Gene: A Mosaic of Exons Shared with Different Proteins
Südhof, T. C., Goldstein, J. L., Brown, M. S., & Russell, D. W. (1985) · Science · doi:10.1126/science.2988123 · Cited by 850 · see citing works
Self-citationShimano, H., Horton, J. D., Hammer, R. E., Shimomura, I., Brown, M. S., & Goldstein, J. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118951 · Cited by 810 · see citing works
Self-citationEndo, A., Kuroda, M., & Tanzawa, K. (1976) · FEBS Letters · doi:10.1016/0014-5793(76)80996-9 · Cited by 800 · see citing works
Zhang, D.-W., Lagace, T. A., Garuti, R., Zhao, Z., McDonald, M., Horton, J. D., Cohen, J. C., & Hobbs, H. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702027200 · Cited by 788 · see citing works
Shimomura, I., Bashmakov, Y. K., Ikemoto, S., Horton, J. D., Brown, M. S., & Goldstein, J. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13656 · Cited by 779 · see citing works
Self-citationShimomura, I., Shimano, H., Horton, J. D., Goldstein, J. L., & Brown, M. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119247 · Cited by 760 · see citing works
Self-citationFat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196702022760507 · Cited by 750 · see citing works
Anderson, R. G. W., Brown, M. S., & Goldstein, J. L. (1977) · Cell · doi:10.1016/0092-8674(77)90022-8 · Cited by 698 · see citing works
Self-citationSecreted PCSK9 decreases the number of LDL receptors in hepatocytes and inlivers of parabiotic mice
Lagace, T. A., Curtis, D. E., Garuti, R., McNutt, M. C., Park, S. W., Prather, H. B., Anderson, N. N., Ho, Y. K., Hammer, R. E., & Horton, J. D. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29383 · Cited by 681 · see citing works
Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol
Stein, E. A., Mellis, S., Yancopoulos, G. D., Stahl, N., Logan, D., Smith, W. B., Lisbon, E., Gutierrez, M., Webb, C., Wu, R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1105803 · Cited by 664 · see citing works
PCSK9: a convertase that coordinates LDL catabolism
Horton, J. D., Cohen, J. C., & Hobbs, H. H. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800091-jlr200 · Cited by 630 · see citing works
Brown, M. S., & Goldstein, J. L. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.3.788 · Cited by 598 · see citing works
Self-citationThe Biological Synthesis of Cholesterol
Bloch, K. (1965) · Science · doi:10.1126/science.150.3692.19 · Cited by 562 · see citing works
Radhakrishnan, A., Goldstein, J. L., McDonald, J. G., & Brown, M. S. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.10.008 · Cited by 561 · see citing works
Self-citationBrown, M. S., Faust, J. R., Goldstein, J. L., Kaneko, I., & Endo, A. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38120-6 · Cited by 556 · see citing works
Self-citationChen, Z., Peto, R., Collins, R., MacMahon, S. W., Lu, J., & Li, W. (1991) · BMJ · doi:10.1136/bmj.303.6797.276 · Cited by 537 · see citing works
Deaths: Leading Causes for 2017.
Heron, M. P. (2019) · PubMed · Cited by 519 · see citing works
Cholesterol feedback: from Schoenheimer's bottle to Scap's MELADL
Brown, M. S., & Goldstein, J. L. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800054-jlr200 · Cited by 502 · see citing works
Self-citationRaal, F. J., Scott, R. C., Somaratne, R. M., Bridges, I. M., Li, G., Wasserman, S. M., & Stein, E. A. (2012) · Circulation · doi:10.1161/circulationaha.112.144055 · Cited by 502 · see citing works
Sterol Resistance in CHO Cells Traced to Point Mutation in SREBP Cleavage–Activating Protein
Hua, X., Nohturfft, A., Goldstein, J. L., & Brown, M. S. (1996) · Cell · doi:10.1016/s0092-8674(00)81362-8 · Cited by 478 · see citing works
Self-citationRawson, R. B., Zelenski, N. G., Nijhawan, D., Ye, J., Sakai, J., Hasan, M. T., Chang, T., Brown, M. S., & Goldstein, J. L. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80006-4 · Cited by 471 · see citing works
Self-citationOxidized Low-Density Lipoprotein and Atherosclerosis
Steinberg, D. H., & Witztum, J. L. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.179697 · Cited by 460 · see citing works
Goldstein, J. L., & Brown, M. S. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.10.2804 · Cited by 454 · see citing works
Self-citationRegulatory role for hepatic low density lipoprotein receptors in vivo in the dog.
Kovanen, P. T., Bilheimer, D. W., Goldstein, J. L., Jaramillo, J. J., & Brown, M. S. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.2.1194 · Cited by 421 · see citing works
Self-citationInactivating Mutations in <i>NPC1L1</i> and Protection from Coronary Heart Disease
The Myocardial Infarction Genetics Consortium Investigators (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1405386 · Cited by 419 · see citing works
Brown, A. J., Sun, L., Feramisco, J. D., Brown, M. S., & Goldstein, J. L. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00591-9 · Cited by 417 · see citing works
Self-citationSakai, J., Rawson, R. B., Espenshade, P. J., Cheng, D., Seegmiller, A. C., Goldstein, J. L., & Brown, M. S. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80150-1 · Cited by 405 · see citing works
Self-citationSchneider, W. J., Beisiegel†, U., Goldstein, J. L., & Brown, M. S. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34975-5 · Cited by 376 · see citing works
Self-citationDirect Binding of Cholesterol to the Purified Membrane Region of SCAP
Radhakrishnan, A., Sun, L.-P., Kwon, H. J., Brown, M. S., & Goldstein, J. L. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.06.019 · Cited by 333 · see citing works
Self-citationStein, E. A., Honarpour, N., Wasserman, S. M., Xu, F., Scott, R. C., & Raal, F. J. (2013) · Circulation · doi:10.1161/circulationaha.113.004678 · Cited by 330 · see citing works
Moon, Y.-A., Liang, G., Xie, X., Frank-Kamenetsky, M., Fitzgerald, K., Koteliansky, V., Brown, M. S., Goldstein, J. L., & Horton, J. D. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.017 · Cited by 320 · see citing works
Self-citationDeaths: leading causes for 2010.
Heron, M. P. (2013) · PubMed · Cited by 317 · see citing works
Sun, L.-P., Seemann, J., Goldstein, J. L., & Brown, M. S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700907104 · Cited by 309 · see citing works
Self-citationIndependent regulation of sterol regulatory element-binding proteins 1 and 2 in hamster liver.
Sheng, Z., Otani, H., Brown, M. S., & Goldstein, J. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.935 · Cited by 303 · see citing works
Self-citationWang, X., Briggs, M. R., Hua, X., Yokoyama, C., Goldstein, J. L., & Brown, M. S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85266-3 · Cited by 299 · see citing works
Self-citationBucher, N. L. R., Overath, P., & Lynen, F. (1960) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(60)91390-1 · Cited by 290 · see citing works
The inheritance of essential familial hypercholesterolemia
Khachadurian, A. K. (1964) · The American Journal of Medicine · doi:10.1016/0002-9343(64)90196-2 · Cited by 280 · see citing works
Mabuchi, H., Haba, T., Tatami, R., Miyamoto, S., Sakai, Y., Wakasugi, T., Watanabe, A., Koizumi, J., & Takeda, R. (1981) · New England Journal of Medicine · doi:10.1056/nejm198108273050902 · Cited by 262 · see citing works
LESSONS FROM SERUM CHOLESTEROL STUDIES IN JAPAN, HAWAII AND LOS ANGELES
Keys, A. B., KIMURA, N., Kusukawa, A., Bronte‐Stewart, B., Larsen, N. P., & Keys, M. (1958) · Annals of Internal Medicine · doi:10.7326/0003-4819-48-1-83 · Cited by 256 · see citing works
The macrophage scavenger receptor at 30 years of age: current knowledge and future challenges
Greaves, D. R., & Gordon, S. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800066-jlr200 · Cited by 248 · see citing works
Structure of a Site-2 Protease Family Intramembrane Metalloprotease
Feng, L., Yan, H., Wu, Z., Yan, N., Wang, Z., Jeffrey, P. D., & Shi, Y. (2007) · Science · doi:10.1126/science.1150755 · Cited by 224 · see citing works
Sakai, J., Nohturfft, A., Goldstein, J. L., & Brown, M. S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5785 · Cited by 222 · see citing works
Self-citationER export: public transportation by the COPII coach
Antonny, B., & Schekman, R. W. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00234-9 · Cited by 209 · see citing works
Lowering LDL—not only how low, but how long?
Brown, M. S., & Goldstein, J. L. (2006) · Science · doi:10.1126/science.1125884 · Cited by 204 · see citing works
Self-citationXanthomata, Hypercholesterolemia, Angina Pectoris.
Müller, C. (1938) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1938.tb19279.x · Cited by 202 · see citing works
Usifo, E., Leigh, S. E. A., Whittall, R., Lench, N., Taylor, A., Yeats, C., Orengo, C. A., Martin, A. C. R., Celli, J., & Humphries, S. E. (2012) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2012.00724.x · Cited by 201 · see citing works
Steinberg, D. H. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r400012-jlr200 · Cited by 185 · see citing works
A<i>PCSK9</i>Missense Variant Associated with a Reduced Risk of Early-Onset Myocardial Infarction
Kathiresan, S. (2008) · New England Journal of Medicine · doi:10.1056/nejmc0707445 · Cited by 183 · see citing works
The distribution and composition of serum lipoproteins in eighteen animals
MILLS, G. L., & Taylaur, C. E. (1971) · Comparative Biochemistry and Physiology Part B Comparative Biochemistry · doi:10.1016/0305-0491(71)90234-3 · Cited by 163 · see citing works
NEONATAL DIAGNOSIS OF FAMILIAL TYPE-II HYPERLIPOPROTEINÆMIA
Kwiterovich, P., Levy, R., & Fredrickson, D. (1973) · The Lancet · doi:10.1016/s0140-6736(73)90194-3 · Cited by 154 · cited 1× · see citing works
“In newborn humans, LDL cholesterol is less than 50mg/dl (Kwiterovich et al., 1973).”
Hua, X., Sakai, J., K., H. Y., Goldstein, J. L., & Brown, M. S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.49.29422 · Cited by 154 · see citing works
Self-citationTHROMBOSIS OF THE CORONARY ARTERIES
HERRICK, J. B. (1919) · JAMA · doi:10.1001/jama.1919.02610060001001 · Cited by 152 · see citing works
SYNTHESIS AND DESTRUCTION OF CHOLESTEROL IN THE ORGANISM
Schoenheimer, R., & Breusch, F. (1933) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)75823-7 · Cited by 148 · see citing works
Gofman, J. W., DELALLA, O., Glazier, F., FREEMAN, N. K., Lindgren, F. T., Nichols, A. V., Strisower, B., & Tamplin, A. R. (2007) · Journal of clinical lipidology · doi:10.1016/j.jacl.2007.03.001 · Cited by 130 · see citing works
The Discovery of Cellular Immunity in the Atherosclerotic Plaque
Hansson, G. K., & Jonasson, L. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.179713 · Cited by 118 · see citing works
Gofman, J. W., Rubin, L., McGinley, J. P., & Jones, H. B. (1954) · The American Journal of Medicine · doi:10.1016/0002-9343(54)90126-6 · Cited by 114 · see citing works
Abifadel, M., Elbitar, S., Khoury, P. E., Ghaleb, Y., Chemaly, M., Moussalli, M.-L., Rabès, J., Varret, M., & Boileau, C. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0439-8 · Cited by 102 · see citing works
The History of Coronary Heart Disease
Leibowitz, J. O. (1970) · University of California Press eBooks · doi:10.1525/9780520337688 · Cited by 101 · see citing works
Motamed, M., Zhang, Y., Wang, M. L., Seemann, J., Kwon, H. J., Goldstein, J. L., & Brown, M. S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.238311 · Cited by 98 · see citing works
Self-citationChapman, M. J., & Goldstein, S. (1976) · Atherosclerosis · doi:10.1016/0021-9150(76)90033-2 · Cited by 92 · see citing works
Diet, Life-Style and Mortality in China
Donnan, S. (1992) · Journal of Epidemiology & Community Health · doi:10.1136/jech.46.4.462-b · Cited by 90 · see citing works
Uauy, R. D., Vega, G. L., Grundy, S. M., & Bilheimer, D. W. (1988) · The Journal of Pediatrics · doi:10.1016/s0022-3476(88)80289-0 · Cited by 85 · see citing works
Coronary Heart Disease in Young Adults: A Multidisciplinary Study
(1957) · Diabetes · doi:10.2337/diab.6.1.105a · Cited by 79 · see citing works
Influence of lovastatin therapy on metabolism of low density lipoproteins in mixed hyperlipidaemia
Vega, G. L., & Grundy, S. M. (1991) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1991.tb00454.x · Cited by 46 · see citing works
Lowering Plasma Cholesterol by Raising LDL Receptors — Revisited
Young, S. G., & Fong, L. G. (2012) · New England Journal of Medicine · doi:10.1056/nejme1202168 · Cited by 36 · see citing works
Beginnings of feedback inhibition, allostery, and multi-protein complexes
Pardee, A. B. (2003) · Gene · doi:10.1016/s0378-1119(03)00839-4 · Cited by 35 · see citing works
Vogel, R. A. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.03.011 · Cited by 33 · see citing works
Coronary Heart Disease in Young Adults: A Multidisciplinary Study
(1954) · JAMA · doi:10.1001/jama.1954.02950110086032 · Cited by 32 · see citing works
The history of coronary heart disease
Leigh, D. (1971) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(71)90061-4 · Cited by 27 · see citing works
Mechanisms and cellular functions of intramembrane proteases
Urban, S. (2013) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2013.07.001 · Cited by 23 · see citing works
Mabuchi, H., Haba, T., TATAMI, R., Miyamoto, S., Sakai, Y., WAKASUGI, T., Watanabe, A., Koizumi, J., & Takeda, R. (2004) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2004.08.023 · Cited by 21 · see citing works
Statins for primary prevention of coronary artery disease
Mascitelli, L., & Pezzetta, F. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60518-2 · Cited by 20 · see citing works
Combating the Epidemic of Heart Disease
Levy, D. A. (2012) · JAMA · doi:10.1001/jama.2012.164971 · Cited by 19 · see citing works
The origin of a useful concept – Feedback inhibition
Umbarger, H. E. (1992) · Protein Science · doi:10.1002/pro.5560011019 · Cited by 17 · see citing works
An intimate account of my early experience with coronary thrombosis
HERRICK, J. B. (1944) · American Heart Journal · doi:10.1016/s0002-8703(44)90602-2 · Cited by 17 · see citing works
Statins for primary prevention of coronary artery disease
McPherson, R., & Kavaslar, N. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60516-9 · Cited by 13 · see citing works
Statins for primary prevention of coronary artery disease
Reidenberg, M. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60517-0 · Cited by 6 · see citing works
The 1964 Nobel Prize for the discovery of the biosynthesis of cholesterol
Zetterström, R. H. (2009) · Acta Paediatrica · doi:10.1111/j.1651-2227.2009.01282.x · Cited by 5 · see citing works
Flagged first, then by citations
3 of the 115 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Goldstein JL Hobbs HH Brown MS Scriver CR Beaudet AL Sly WS Valle D Familial hypercholesterolemia. The Metabolic and Molecular Bases of Inherited Disease 2001 2863 2913 McGraw-Hill, Inc. New York 8th.
Cited by
Sorted by citations
Ference, B. A., Ginsberg, H. N., Graham, I., Ray, K. K., Packard, C. J., Bruckert, E., Hegele, R. A., Krauss, R. M., Raal, F. J., Schunkert, H., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx144 · Cited by 3,962 · see citing works
Libby, P., Buring, J. E., Badimon, L., Hansson, G. K., Deanfield, J., Bittencourt, M. S., Tokgözoğlu, L., & Lewis, E. F. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0106-z · Cited by 3,211 · see citing works
The changing landscape of atherosclerosis
Libby, P. (2021) · Nature · doi:10.1038/s41586-021-03392-8 · Cited by 2,873 · see citing works
Sanderson, E., Glymour, M. M., Holmes, M. V., Kang, H., Morrison, J., Munafò, M. R., Palmer, T., Schooling, C. M., Wallace, C., Zhao, Q., et al. (2022) · Nature Reviews Methods Primers · doi:10.1038/s43586-021-00092-5 · Cited by 2,229 · see citing works
Borén, J., Chapman, M. J., Krauss, R. M., Packard, C. J., Bentzon, J. F., Binder, C. J., Daemen, M. J., Demer, L. L., Hegele, R. A., Nicholls, S. J., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz962 · Cited by 1,601 · see citing works
Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol
Ray, K. K., Landmesser, U., Leiter, L. A., Kallend, D., Dufour, R., Karakas, M., Hall, T., Troquay, R. P. T., Turner, T., Visseren, F. L. J., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1615758 · Cited by 992 · see citing works
Richardson, T. G., Sanderson, E., Palmer, T. M., Ala-Korpela, M., Ference, B. A., Davey Smith, G., & Holmes, M. V. (2020) · PLOS Medicine · doi:10.1371/journal.pmed.1003062 · Cited by 843 · see citing works
Lipid metabolism reprogramming and its potential targets in cancer
Cheng, C., Geng, F., Cheng, X., & Guo, D. (2018) · 癌症：英文版 · doi:10.1186/s40880-018-0301-4 · Cited by 862 · see citing works
Lipolysis: cellular mechanisms for lipid mobilization from fat stores
Grabner, G. F., Xie, H., Schweiger, M., & Zechner, R. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00493-6 · Cited by 771 · see citing works
Health Benefits of the Mediterranean Diet: Metabolic and Molecular Mechanisms
Tosti, V., Bertozzi, B., & Fontana, L. (2018) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glx227 · Cited by 762 · see citing works
A brief history of human disease genetics
Claussnitzer, M., Cho, J. H., Collins, R., Cox, N. J., Dermitzakis, E. T., Hurles, M. E., Kathiresan, S., Kenny, E. E., Lindgren, C. M., MacArthur, D. G., et al. (2020) · Nature · doi:10.1038/s41586-019-1879-7 · Cited by 697 · see citing works
The interplay between cell signalling and the mevalonate pathway in cancer
Mullen, P., Yu, R., Longo, J., Archer, M. C., & Penn, L. Z. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.76 · Cited by 697 · see citing works
The Klotho proteins in health and disease
Kuro-o, M. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0078-3 · Cited by 707 · see citing works
The Lysosome as a Regulatory Hub
Perera, R. M., & Zoncu, R. (2016) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-111315-125125 · Cited by 664 · see citing works
A Quarter Century of APOE and Alzheimer’s Disease: Progress to Date and the Path Forward
Belloy, M. E., Napolioni, V., & Greicius, M. D. (2019) · Neuron · doi:10.1016/j.neuron.2019.01.056 · Cited by 570 · see citing works
Lysosomal cholesterol activates mTORC1 via an SLC38A9–Niemann-Pick C1 signaling complex
Castellano, B. M., Thelen, A. M., Moldavski, O., Feltes, M., van der Welle, R. E. N., Mydock-McGrane, L., Jiang, X., van Eijkeren, R. J., Davis, O. B., Louie, S. M., et al. (2017) · Science · doi:10.1126/science.aag1417 · Cited by 562 · see citing works
ApoE2, ApoE3, and ApoE4 Differentially Stimulate APP Transcription and Aβ Secretion
Huang, Y.-W. A., Zhou, B., Wernig, M., & Südhof, T. C. (2017) · Cell · doi:10.1016/j.cell.2016.12.044 · Cited by 528 · see citing works
Cytosolic lipolysis and lipophagy: two sides of the same coin
Zechner, R., Madeo, F., & Kratky, D. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.76 · Cited by 550 · see citing works
Inflammation, Immunity, and Infection in Atherothrombosis
Libby, P., Loscalzo, J., Ridker, P. M., Farkouh, M. E., Hsue, P. Y., Fuster, V., Hasan, A. A., & Amar, S. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.08.1043 · Cited by 548 · see citing works
Impact of Lipids on Cardiovascular Health
Ference, B. A., Graham, I., Tokgozoglu, L., & Catapano, A. L. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.06.046 · Cited by 511 · see citing works
Selective autophagy of intracellular organelles: Recent research advances
Li, W., He, P., Huang, Y., Li, Y.-F., Lu, J., Li, M., Kurihara, H., Luo, Z., Meng, T., Onishi, M., et al. (2020) · Theranostics · doi:10.7150/thno.49860 · Cited by 510 · see citing works
Duan, Y., Gong, K., Xu, S., Zhang, F., Meng, X., & Han, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01125-5 · Cited by 538 · see citing works
Ertunc, M. E., & Hotamışlıgil, G. S. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r066514 · Cited by 485 · see citing works
Mechanistic Insights into the Oxidized Low-Density Lipoprotein-Induced Atherosclerosis
Khatana, C., Saini, N. K., Chakrabarti, S., Saini, V., Sharma, A. K., Saini, R. V., & Saini, A. K. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5245308 · Cited by 481 · see citing works
Kraus, W. E., Bhapkar, M., Huffman, K. M., Pieper, C. F., Krupa Das, S., Redman, L. M., Villareal, D. T., Rochon, J., Roberts, S. B., Ravussin, E., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30151-2 · Cited by 407 · see citing works
Angiogenesis in the atherosclerotic plaque
Camaré, C., Pucelle, M., Nègre-Salvayre, A., & Salvayre, R. (2017) · Redox Biology · doi:10.1016/j.redox.2017.01.007 · Cited by 401 · see citing works
Rab GTPase Function in Endosome and Lysosome Biogenesis
Langemeyer, L., Fröhlich, F., & Ungermann, C. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.06.007 · Cited by 393 · see citing works
Wilde, A., Semsarian, C., Márquez, M., Shamloo, A. S., Ackerman, M., Ashley, E. A., Sternick, E., Barajas-Martinez, H., Behr, E., Bezzina, C., et al. (2022) · Europace · doi:10.1093/europace/euac030 · Cited by 216 · see citing works
Inflammation in acute myocardial infarction: the good, the bad and the ugly
Matter, M. A., Paneni, F., Libby, P., Frantz, S., Stähli, B. E., Templin, C., Mengozzi, A., Wang, Y.-J., Kündig, T. M., Räber, L., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad486 · Cited by 381 · see citing works
APOE and Alzheimer’s Disease: From Lipid Transport to Physiopathology and Therapeutics
Husain, M. A., Laurent, B., & Plourde, M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.630502 · Cited by 353 · see citing works
Ravnskov, U., Diamond, D. M., Hama, R., Hamazaki, T., Hammarskjöld, B., Hynes, N., Kendrick, M. E., Langsjoen, P. H., Malhotra, A., Mascitelli, L., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010401 · Cited by 343 · see citing works
Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease
Gourdie, R. G., Dimmeler, S., & Kohl, P. K. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.89 · Cited by 329 · see citing works
Human SRMAtlas: A Resource of Targeted Assays to Quantify the Complete Human Proteome
Kusebauch, U., Campbell, D. S., Deutsch, E. W., Chu, C. S., Spicer, D. A., Brusniak, M.-Y., Slagel, J., Sun, Z., Stevens, J., Grimes, B., et al. (2016) · Cell · doi:10.1016/j.cell.2016.06.041 · Cited by 310 · see citing works
Systems proteomics of liver mitochondria function
Williams, E. G., Wu, Y., Jha, P., Dubuis, S., Blattmann, P., Argmann, C. A., Houten, S. M., Amariuta, T., Wolski, W., Zamboni, N., et al. (2016) · Science · doi:10.1126/science.aad0189 · Cited by 289 · see citing works
Regulation of glucose and lipid metabolism in health and disease
Chen, L., Chen, X., Huang, X., Song, B., Wang, Y., & Wang, Y. (2019) · Science China Life Sciences · doi:10.1007/s11427-019-1563-3 · Cited by 309 · see citing works
Cholesterol Metabolism by Uncultured Human Gut Bacteria Influences Host Cholesterol Level
Kenny, D. J., Plichta, D. R., Shungin, D., Koppel, N., Hall, A. B., Fu, B., Vasan, R. S., Shaw, S. Y., Vlamakis, H. C., Balskus, E. P., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.05.013 · Cited by 311 · see citing works
Introduction to Lipids and Lipoproteins
Feingold, K. R., & Grünfeld, C. (2015) · MDText.com, Inc. eBooks · Cited by 306 · see citing works
An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer
Chen, M., Zhang, J., Sampieri, K., Clohessy, J. G., Mendez, L., González‐Billalabeitia, E., Liu, X., Lee, Y.-R., Fung, J., Katon, J. M., et al. (2018) · Nature Genetics · doi:10.1038/s41588-017-0027-2 · Cited by 291 · see citing works
From Focal Lipid Storage to Systemic Inflammation
Libby, P., & Hansson, G. K. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.07.061 · Cited by 289 · see citing works
NPC1 regulates ER contacts with endocytic organelles to mediate cholesterol egress
Höglinger, D., Burgoyne, T., Sánchez-Heras, E., Hartwig, P., Colaço, A., Newton, J. C., Futter, C. E., Spiegel, S., Platt, F. M., & Eden, E. R. (2019) · Nature Communications · doi:10.1038/s41467-019-12152-2 · Cited by 280 · see citing works
Sandhu, J., Li, S., Fairall, L., Pfisterer, S. G., Gurnett, J. E., Xiao, X., Weston, T. A., Vashi, D., Ferrari, A., Orozco, J. L., et al. (2018) · Cell · doi:10.1016/j.cell.2018.08.033 · Cited by 287 · see citing works
Microglia in Alzheimer’s disease: pathogenesis, mechanisms, and therapeutic potentials
Miao, J., Ma, H., Yang, Y., Liao, Y., Lin, C., Zheng, J., Yu, M., & Lan, J. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1201982 · Cited by 293 · see citing works
Sharifi‐Rad, J., Rodrigues, C. F., Sharopov, F. S., Docea, A. O., Karaça, A. C., Sharifi‐Rad, M., Kahveci, D., Gülseren, G., Şenol, E., Demircan, E., et al. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17072326 · Cited by 295 · see citing works
Inter-organ cross-talk in metabolic syndrome
Priest, C., & Tontonoz, P. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0145-5 · Cited by 279 · see citing works
Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target
Liu, D., Wong, C. C., Fu, L., Chen, H., Zhao, L., Li, C., Zhou, Y., Zhang, Y., Xu, W., Yang, Y., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aap9840 · Cited by 278 · see citing works
Wilde, A., Semsarian, C., Márquez, M., Shamloo, A. S., Ackerman, M., Ashley, E., Sternick, E., Barajas-Martinez, H., Behr, E., Bezzina, C., et al. (2022) · Heart Rhythm · doi:10.1016/j.hrthm.2022.03.1225 · Cited by 174 · see citing works
Goul, C., Peruzzo, R., & Zoncu, R. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00641-8 · Cited by 269 · see citing works
Sinha, R. A., Bruinstroop, E., Singh, B. K., & Yen, P. M. (2019) · Thyroid · doi:10.1089/thy.2018.0664 · Cited by 272 · see citing works
Emerging Roles for the Lysosome in Lipid Metabolism
Thelen, A. M., & Zoncu, R. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.07.006 · Cited by 268 · see citing works
Zhang, Y., Pletcher, M. J., Vittinghoff, E., Clemons, A. M., Jacobs, D. R., Allen, N. B., Alonso, A., Bellows, B. K., Oelsner, E. C., Zeki Al Hazzouri, A., et al. (2021) · JAMA Cardiology · doi:10.1001/jamacardio.2021.3508 · Cited by 257 · see citing works
Atherosclerosis at arterial bifurcations: evidence for the role of haemodynamics and geometry
Morbiducci, U., Kok, A. M., Kwak, B. R., Stone, P. H., Steinman, D. A., & Wentzel, J. J. (2016) · Thrombosis and Haemostasis · doi:10.1160/th15-07-0597 · Cited by 258 · see citing works
Pathogenesis of Atherosclerosis: A Multifactorial Process
Buja, L. M. (2023) · Springer eBooks · doi:10.1007/978-3-031-25879-4_2 · Cited by 252 · see citing works
Physiological and pathological roles of lipogenesis
Jeon, Y. G., Kim, Y. Y., Lee, G., & Kim, J. B. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00786-y · Cited by 248 · see citing works
Coronary heart disease risk: Low-density lipoprotein and beyond
Shaya, G. E., Leucker, T. M., Jones, S. R., Martin, S. S., & Toth, P. P. (2021) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2021.04.002 · Cited by 243 · see citing works
Cross-species regulatory sequence activity prediction
Kelley, D. R. (2020) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1008050 · Cited by 228 · see citing works
Orthogonal lipid sensors identify transbilayer asymmetry of plasma membrane cholesterol
Liu, S.-L., Sheng, R., Jung, J. H., Wang, L., Stec, E., O'Connor, M. J., Song, S., Bikkavilli, R. K., Winn, R. A., Lee, D., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2268 · Cited by 239 · see citing works
Structural basis for the recognition of Sonic Hedgehog by human Patched1
Gong, X., Qian, H., Cao, P., Zhao, X., Zhou, Q., Lei, J., & Yan, N. (2018) · Science · doi:10.1126/science.aas8935 · Cited by 216 · see citing works
Wright, R. S., Ray, K. K., Raal, F. J., Kallend, D. G., Jaros, M., Koenig, W., Leiter, L. A., Landmesser, U., Schwartz, G. G., Friedman, A., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.12.058 · Cited by 229 · see citing works
Lysosomal storage disorders – challenges, concepts and avenues for therapy: beyond rare diseases
Marques, A. R. A., & Säftig, P. (2019) · Journal of Cell Science · doi:10.1242/jcs.221739 · Cited by 224 · see citing works
SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formation
Sanders, D. W., Jumper, C. C., Ackerman, P. J., Bracha, D., Donlic, A., Kim, H., Kenney, D., Castello-Serrano, I., Suzuki, S., Tamura, T., et al. (2021) · eLife · doi:10.7554/elife.65962 · Cited by 215 · see citing works
Simvastatin induced ferroptosis for triple-negative breast cancer therapy
Yao, X., Xie, R., Cao, Y., Tang, J., Men, Y., Peng, H., & Yang, W. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01058-1 · Cited by 227 · see citing works
Applications and Limitations of Mouse Models for Understanding Human Atherosclerosis
von Scheidt, M., Zhao, Y., Kurt, Z., Pan, C., Zeng, L., Yang, X., Schunkert, H., & Lusis, A. J. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.11.001 · Cited by 220 · see citing works
Lipoprotein receptor signalling in atherosclerosis
Mineo, C. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz338 · Cited by 220 · see citing works
The Role of Gut Microbiota on Cholesterol Metabolism in Atherosclerosis
Vourakis, M., Mayer, G., & Rousseau, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158074 · Cited by 219 · see citing works
Jung, E., Kong, S. Y., Ro, Y. S., Ryu, H. H., & Shin, S. D. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19148272 · Cited by 231 · see citing works
Jia, B., Zou, Y., Han, X., Bae, J., & Jeon, C. O. (2022) · Trends in Microbiology · doi:10.1016/j.tim.2022.08.003 · Cited by 220 · see citing works
Xiao, C., Dash, S., Morgantini, C., Hegele, R. A., & Lewis, G. F. (2016) · Diabetes · doi:10.2337/db16-0046 · Cited by 212 · see citing works
Impact of Cholesterol Metabolism in Immune Cell Function and Atherosclerosis
Aguilar-Ballester, M., Herrero-Cervera, A., Vinué, Á., Martínez‐Hervás, S., & Navarro, H. G. (2020) · Nutrients · doi:10.3390/nu12072021 · Cited by 208 · see citing works
Lipid and Lipoprotein Metabolism
Feingold, K. R. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2022.02.008 · Cited by 198 · see citing works
Annexin A1 Tethers Membrane Contact Sites that Mediate ER to Endosome Cholesterol Transport
Eden, E. R., Sánchez-Heras, E., Tsapara, A., Sobota, A., Levine, T. P., & Futter, C. E. (2016) · Developmental Cell · doi:10.1016/j.devcel.2016.05.005 · Cited by 196 · see citing works
Carr, S. S., Hooper, A. J., SULLIVAN, D. R., & Burnett, J. R. (2018) · Pathology · doi:10.1016/j.pathol.2018.11.006 · Cited by 197 · see citing works
Could Ceramides Become the New Cholesterol?
Summers, S. A. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.12.003 · Cited by 184 · see citing works
The LDL cumulative exposure hypothesis: evidence and practical applications
Ference, B. A., D, E. B. M., & Catapano, A. L. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01039-5 · Cited by 191 · see citing works
Vascular Smooth Muscle Cells Phenotypic Switching in Cardiovascular Diseases
Tang, H., Chen, A., Zhang, H., Gao, X., Kong, X., & Zhang, J. (2022) · Cells · doi:10.3390/cells11244060 · Cited by 177 · see citing works
Statins: Old drugs as new therapy for liver diseases?
Pose, E., Trebicka, J., Mookerjee, R. P., Angeli, P., & Ginès, P. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.07.019 · Cited by 176 · see citing works
Movement of accessible plasma membrane cholesterol by the GRAMD1 lipid transfer protein complex
Naito, T., Ercan, B., Krshnan, L., Triebl, A., Koh, D. H. Z., Wei, F.-Y., Tomizawa, K., Torta, F. T., Wenk, M. R., & Saheki, Y. (2019) · eLife · doi:10.7554/elife.51401 · Cited by 171 · see citing works
Lipid-Lowering Agents: Targets Beyond PCSK9
Hegele, R. A., & Tsimikas, S. (2019) · Circulation Research · doi:10.1161/circresaha.118.313171 · Cited by 171 · see citing works
Microdomains, Inflammation, and Atherosclerosis
Sorci-Thomas, M. G., & Thomas, M. J. (2016) · Circulation Research · doi:10.1161/circresaha.115.306246 · Cited by 165 · see citing works
ApoE, ApoE Receptors, and the Synapse in Alzheimer's Disease
Lane-Donovan, C., & Herz, J. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.12.001 · Cited by 157 · see citing works
“The first identified member of the LDL receptor family, LDLR, is expressed on the cell surface of hepatocytes and binds LDL particles through Apolipoprotein B (ApoB); similarly, LDLR and LRP1 bind ApoE on chylomicron remnants and VLDL particles [2].”
BackgroundRORγ is a targetable master regulator of cholesterol biosynthesis in a cancer subtype
Cai, D., Wang, J., Gao, B., Li, J., Wu, F., Zou, J. X., Xu, J., Jiang, Y., Zou, H., Huang, Z., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12529-3 · Cited by 167 · see citing works
Cholesterol and beyond - The role of the mevalonate pathway in cancer biology
Göbel, A., Rauner, M., Hofbauer, L. C., & Rachner, T. D. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188351 · Cited by 165 · see citing works
Lipids and Their Trafficking: An Integral Part of Cellular Organization
Jackson, C. L., Walch, L., & Verbavatz, J. (2016) · Developmental Cell · doi:10.1016/j.devcel.2016.09.030 · Cited by 162 · see citing works
Landmesser, U., Chapman, M. J., Farnier, M., Gencer, B., Gielen, S., Hovingh, G. K., Lüscher, T. F., Sinning, D., Tokgözoğlu, L. S., Wiklund, O., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw480 · Cited by 162 · see citing works
Analytical methods for cholesterol quantification
Li, L., Dutkiewicz, E. P., Huang, Y.-C., Zhou, H.-B., & Hsu, C. (2018) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2018.09.001 · Cited by 161 · see citing works
MiT/TFE Family of Transcription Factors, Lysosomes, and Cancer
Perera, R. M., Malta, C. D., & Ballabio, A. (2018) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055835 · Cited by 157 · see citing works
Stearoyl CoA desaturase-1: New insights into a central regulator of cancer metabolism
Igal, R. A. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.09.009 · Cited by 159 · see citing works
Infante, R. E., & Radhakrishnan, A. (2017) · eLife · doi:10.7554/elife.25466 · Cited by 158 · see citing works
Kim, I.-S., Kim, C., & Yang, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084054 · Cited by 170 · see citing works
Structure and inhibition mechanism of the catalytic domain of human squalene epoxidase
Padyana, A. K., Größ, S., Jin, L., Cianchetta, G., Narayanaswamy, R., Wang, F., Wang, R. Y., Cheng, F., Lv, X., Biller, S. A., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-07928-x · Cited by 158 · see citing works
TMEM41B acts as an ER scramblase required for lipoprotein biogenesis and lipid homeostasis
Huang, D., Xu, B., Liu, L., Wu, L., Zhu, Y., Ghanbarpour, A., Wang, Y., Chen, F., Lyu, J., Hu, Y., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.05.006 · Cited by 157 · see citing works
Kusnadi, A., Park, S. H., Yuan, R., Pannellini, T., Γιαννοπούλου, Ε., Oliver, D., Lu, T. T., Park‐Min, K., & Ivashkiv, L. B. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.005 · Cited by 156 · see citing works
Wright, R. S., Collins, M. G., Stoekenbroek, R. M., Robson, R. A., Wijngaard, P. L. J., Landmesser, U., Leiter, L. A., Kastelein, J. J. P., Ray, K. K., & Kallend, D. G. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.08.021 · Cited by 158 · see citing works
Zhang, X., Zhang, Y., Wang, P., Zhang, S., Dong, Y., Zeng, G., Yan, Y., Sun, L., Wu, Q., Liu, H., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.09.016 · Cited by 152 · see citing works
Esquejo, R. M., Salatto, C. T., Delmore, J. E., Albuquerque, B., Reyes, A. R., Shi, Y., Moccia, R., Cokorinos, E., Peloquin, M., Monetti, M., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.04.009 · Cited by 148 · see citing works
Mitochondria-rough-ER contacts in the liver regulate systemic lipid homeostasis
Anastasia, I., Ilacqua, N., Raimondi, A., Lemieux, P., Ghandehari‐Alavijeh, R., Faure, G., Mekhedov, S., Williams, K. J., Caicci, F., Valle, G., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108873 · Cited by 148 · see citing works
Casanova, J., & Abel, L. (2022) · Cell · doi:10.1016/j.cell.2022.07.004 · Cited by 145 · see citing works
Jeong, A., Suazo, K. F., Wood, W. G., Distefano, M. D., & Li, L. (2018) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2018.1458070 · Cited by 146 · see citing works
Cholesterol access in cellular membranes controls Hedgehog signaling
Radhakrishnan, A., Rohatgi, R., & Siebold, C. (2020) · Nature Chemical Biology · doi:10.1038/s41589-020-00678-2 · Cited by 146 · see citing works
Novel antiatherosclerotic therapies
Libby, P., & Everett, B. M. (2019) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.118.310958 · Cited by 145 · see citing works
The Molecular Basis of Predicting Atherosclerotic Cardiovascular Disease Risk
Nayor, M. G., Brown, K., & Vasan, R. S. (2021) · Circulation Research · doi:10.1161/circresaha.120.315890 · Cited by 147 · see citing works
- Authors
- Goldstein, J. L., & Brown, M. S.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Goldstein, Joseph L.
- Brown, Michael S.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 161
- Issue
- 1
- Pages
- 161-172
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC4525717
- OpenAlex
- W2160347316
- Cited by
- 1,233
- References
- 115
- Citations by year
- 2026: 101 · 2025: 134 · 2024: 117 · 2023: 121 · 2022: 136 · 2021: 150 · 2020: 116 · 2019: 105 · 2018: 87 · 2017: 84 · 2016: 61 · 2015: 19 · 2014: 1
- FWCI
- 16.03
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Regeneron Pharmaceuticals
- National Heart, Lung, and Blood Institute (HL-20948, P01HL020948)
- Topics
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Keywords
- cholesterol, coronary artery disease, low-density lipoprotein, LDL receptor, LDLR mutations, familial hypercholesterolemia, statins, lipid-lowering therapy, atherosclerosis
- MeSH terms
- Animals, Cardiovascular Diseases, Cholesterol, Coronary Vessels, Dietary Fats, Humans, Receptors, LDL, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Plaque, Atherosclerotic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
